Yes looks like we are headed back up....very excited..this was a top pick on BNN(Canada) and the analyst stated that the company is awaiting 2 phase 3 decisions by FDA, some analysts have a price target of $160-$175
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.